🇺🇸

US SEC Filing Intelligence

· daily

All DOD Contracts — October 29, 2026

The single contract in this period is a $30,093,702 firm-fixed-price delivery order awarded by the Department of the Army (W072 ENDIST Nashville) to DRC Emergency Services, LLC of Galveston, TX for Hurricane Helene debris removal in the Cherokee National Forest, with performance from 2026-07-27 through 2027-03-24. Although the awarding agency is the Army, the underlying work is disaster-remediation services (NAICS 562119, PSC S208), so the aggregate defense-related count is 0/1 and the signal is best characterized as civilian-style emergency response funded through a DOD installation. The award was full-and-open with no set-aside, the recipient is not designated a small business, and $0 has been outlayed against the obligation at the time of data, leaving revenue realization unverified. Signal strength is low (3/10 neutral, materiality 3/10): this is a modest, non-recurring, event-driven award with no disclosed option structure and no public/private status for the recipient, limiting direct equity relevance. The key watch item is outlay progression from $0 toward $30.09M and any modification to the 2027-03-24 end date or obligation value.

1 total filings
· daily

High-Value Federal Grants ($5M+) — October 29, 2026

The 25 high-value federal grants analyzed total $690.0M in obligations, but only one award ($30.1M to DRC Emergency Services for Army debris removal) is defense-related, leaving 95.6% of value in civilian agencies. The portfolio is dominated by small business set-asides and non-competed awards, with 25 neutral signals and no clear bullish or bearish catalysts. The highest-conviction signal is the $26.0M firm-fixed-price award to Koenig & Bauer Banknote Solutions for Treasury offset presses, which carries a $53.4M ceiling and a 2032 performance horizon. Key risks include $0 outlays on several large awards (e.g., $31.2M Broadleaf, $21.3M Sandow Construction) and the prevalence of non-competed awards (e.g., $33.5M Galapagos Federal Systems) that may face protest or recompete pressure. Investors should watch option exercises and recompete dates, particularly for Lockheed Martin Services' TSA work and General Dynamics IT's GSA order, though direct public-equity exposure is limited.

25 total filings
· daily

DOE Energy Grants — October 29, 2026

This digest covers a single DOE/NNSA award: a $21,967,892 sole-source 8(a) Time and Materials definitive contract to Chenega Healthcare Services LLC (San Antonio, TX, an Alaska Native Corporation-owned 8(a) participant) for medical support services to the Office of Secure Transportation. The award is 100% civilian (0/1 defense-related), with a base-plus-options ceiling of $25,376,749 and $16,479,508 outlayed to date (~75% of obligated funds spent). Signal strength is low (3/10) and materiality is minimal (2/10), so this is not a standalone trading catalyst; its relevance is as a data point on protected 8(a)/ANC set-aside revenue streams in federal healthcare services. The highest-conviction (and only) signal is the non-competitive, protest-resistant nature of the award, which provides revenue durability but no competitive-moat read-through. Key watch item: the contract's current end date of 2026-12-27 coincides with its potential end date, leaving roughly $5.4M of ceiling unobligated and no visible option periods beyond the current ceiling, creating recompete/follow-on uncertainty within the next ~2 months.

1 total filings
· daily

General Federal Contracts — October 29, 2026

This 25-contract, $690.03M stream is overwhelmingly civilian (24 of 25 awards; only one DoD award, DRC Emergency Services' $30.09M Army debris-removal order), dominated by GSA Federal Acquisition Service vehicles ($118.5M across five orders), DHS/TSA/USCIS ($142.7M across five), and Department of State IT/consulting ($53.6M across two). The highest-conviction signal is Koenig & Bauer Banknote Solutions SA's $26.02M firm-fixed-price Bureau of Engraving and Printing offset-press order (materiality 4/10, $53.4M base-plus-options ceiling, performance to 2032), the only award with a traceable listed parent (Koenig & Bauer AG). The dominant structural theme is small-business and socioeconomic set-asides (NV Services 8(a), Broadleaf/Arctic Slope, Chenega, Sandow SDVOSB, MetGreen SDVOSB, A. West, Helicopter Transport) plus non-competed awards (Galapagos $33.46M, Nimbis $32.87M, Airbus DS $22.15M), which limits read-through to public equities. Key risk: $0 outlays reported on several large awards (Galapagos $33.46M, Nimbis $32.87M, Broadleaf $31.25M, Trewon $26.90M, CGI Federal $26.73M, Sandow $21.27M, Halvik $21.27M), meaning revenue recognition is unverified, and the data lists no defense primes of scale beyond Lockheed Martin Services' two aging TSA training orders ($34.89M from 2012 and $26.26M from 2009, both $0 outlayed).

25 total filings
· daily

All NASA Contracts — October 29, 2026

This digest covers two NASA contracts totaling $57,513,801, both civilian and neither defense-related, with an average signal strength of 2.5/10. The largest award is a $36,802,451 cost-plus-fixed-fee delivery order to the California Institute of Technology for Earth System Data Records, of which $30,116,974 (82%) is already outlayed, leaving roughly $6.7 million unspent through 2028. The second is a $20,711,350 firm-fixed-price contract to A. West Enterprise, LLC, a small disadvantaged business, for electrical distribution equipment replacement at NASA Kennedy Space Center, with $13,243,254 (64%) outlayed and performance through 2029. The dominant theme is sustained NASA investment in science data and ground infrastructure, but neither recipient is publicly traded, so direct equity exposure is absent. The highest-conviction signal is the multi-year funding commitment to Caltech/JPL through 2028, though it offers no direct public equity play; the key risk is that both contracts are well into their performance periods with limited remaining upside for public contractors.

2 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 29, 2026

The October 29, 2026 S&P 500 Technology filings present a bifurcated picture: strong fundamental momentum in semiconductor equipment (KLA) and networking (Cisco), offset by a pronounced wave of insider selling across Texas Instruments, Apple, and CrowdStrike. KLA delivered standout Q1 FY2027 results with revenue up 28.9% YoY to $4.14B, net income up 38.1%, and gross margin expanding ~60 bps to 61.9%, though operating cash flow lagged earnings and inventories swelled 12.1% sequentially. Cisco's FY2026 proxy confirms a record year—revenue $63.3B (+12% YoY), GAAP operating margin up 350 bps to 24.3%, and $12.7B returned to shareholders (99% of FCF)—but the non-GAAP margin improvement was only 40 bps, suggesting adjusted profitability is plateauing. Insider activity is uniformly negative: three Texas Instruments directors sold a combined ~$4.3M, CrowdStrike's CEO sold ~$1.13M across 17 transactions, and Apple's GC sold ~$824K, all under pre-arranged plans but clustering on the same day. The absence of forward guidance in these filings limits catalyst visibility, making the December 15 Cisco annual meeting and the next earnings cycle the key near-term checkpoints. Overall, the digest signals a sector still growing but facing rising insider caution and working-capital pressure at the equipment layer.

6 high priority 2 medium 8 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 29, 2026

The 21 filings reveal a market bifurcated by AI infrastructure spending: Amazon, Alphabet, and Intel all posted strong top-line growth (12%, 24.6%, and 21% YoY respectively) driven by cloud and data-center demand, but margin and cash-flow pressures are mounting—Amazon swung to a $42.4B TTM free-cash-flow outflow on $94.8B higher capex, and Alphabet's net income fell 24.3% YoY despite 29.9% operating-income growth due to a $21B swing in other income. Guidance is mixed: Amazon projects AWS growth >40% through 2028, Intel guides Q4 revenue down sequentially to $15–16B with GAAP EPS collapsing to $0.10, and Starbucks expects FY2027 revenue to decline ~1% even as comps turn positive. Insider activity skews bearish: three Texas Instruments directors sold a combined ~$4.3M of stock at ~$302, and Apple's GC sold $824K under a 10b5-1 plan, while Netflix's co-CEO gifted shares. Capital allocation remains shareholder-friendly at Cisco (99% of FCF returned) and Linde ($2.6B buybacks), but Gilead's $12.4B IPR&D charge will produce a GAAP loss per share of $(4.40)–$(4.05) for 2026. Across the stream, the dominant pattern is AI-driven revenue acceleration colliding with elevated capex, tax, and compensation costs, creating a wide dispersion in earnings quality.

11 high priority 10 medium 21 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — October 29, 2026

The October 29, 2026 activist and institutional filing wave is dominated by passive 13G/A amendments (37 of 50 filings) reflecting routine quarterly position updates as of September 30, 2026, with only a handful of active 13D developments. The most consequential events are the EnerSys–Ultralife $16/share cash tender with a 39% holder support agreement, Bubble Holdings' $20M preferred investment in Zevia at $1.448/share with performance-contingent tranches, and a governance crisis at Visium Technologies where the sole director/9.43% holder issued a Good Reason notice amid a former CEO's financial-restatement warning. Activist pressure is building at Nano-X Imaging (8.49% holder opposing a 3x authorized-share increase ahead of a November 18 special meeting) and at Sharps Technology/SkyAI (9.99% holder locked into a tender support and three-year standstill at $0.17 per stapled warrant). Institutional flows show notable exits (CICC out of uCloudlink, Bigger Capital out of BTC Digital, UBS out of APEX Tech, Allen Family Capital fully out of Starz at $21.06–$28.20, D.E. Shaw below 5% in Gossamer after selling into an $8.37–$11.00 range) alongside new 5%+ crossings (Trails Edge in Avalo 5.2%, Carson LLC in GAIA 5.1%, Feis Equities in SPACCircle 9.89%, Fouad Ahmed in Robin Energy 43%). Deutsche Telekom's T-Mobile stake rose passively to 55.9% purely from buybacks, underscoring the mechanical drift of large holders in repurchasing companies.

14 high priority 36 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 29, 2026

The 16-filing batch reveals a financials sector bifurcating into transaction/network compounders and asset-gathering businesses under pressure. Mastercard (net revenue +14% YoY, EPS +22%) and ICE (net revenue +15% YoY, adjusted EPS +18%) delivered record quarters, while T. Rowe Price suffered $28.3B net outflows and Coinbase posted a 34.9% YoY revenue decline with a nine-month swing to a $34.9M net loss. Northern Trust was the standout earnings grower (+40% YoY net income, EPS +48%) but its balance sheet contracted 6% and AUC slipped 1% sequentially, signaling the growth was fee- and market-driven rather than organic. Insider activity skews bearish in aggregate (Capital One's CEO sold ~$17M across five transactions, plus sales at Interactive Brokers, Goldman Sachs, Travelers and Robinhood), yet Truist CEO Michael Lyons bought 25,000 shares (~$1.21M) at $48.36 — a high-conviction counter-signal. Capital allocation remains aggressively shareholder-friendly (ICE returned $2.5B YTD including $1.6B buybacks; Mastercard repurchased $12.0B in nine months, shrinking equity to $6.7B), which supports EPS but is compressing balance-sheet buffers and, at Mastercard, driving interest expense up 34.5% YoY. Key catalysts ahead: ICE's MarketAxess acquisition now expected to close Q1 2027 after early HSR termination, and US Bancorp's immediate CRO resignation creates a governance gap to monitor.

13 high priority 3 medium 16 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 29, 2026

The October 29, 2026 digest for the S&P 500 Energy stream contains two filings: a routine board appointment at Marathon Petroleum (MPC) and a sizable insider sale by SLB's Chief Accounting Officer. Neither filing includes financial results, guidance, capital allocation, or transaction data, so period-over-period trend analysis is not possible from this batch. The dominant actionable signal is the SLB insider sale of 10,047 shares at $53.65 (~$539K), which reduced the CAO's holdings to 12,845 shares — implying roughly 44% of his position was sold, a meaningful conviction signal for a non-CEO executive. MPC's election of David E. Constable (effective March 1, 2027) is a governance positive given his CEO experience at Fluor and Sasol and board seats at Anadarko, Rio Tinto, and ABB, but it carries no near-term financial catalyst. Overall, the batch skews neutral-to-cautious: one negative insider signal, one neutral governance update, and no fundamental data to confirm or refute sector earnings momentum. Investors should treat this as a low-information day and focus on the SLB insider pattern and the MPC board transition timeline as the only differentiated items.

2 high priority 2 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 29, 2026

The 11 filings from S&P 500 Consumer Staples companies reveal a sector navigating a tug-of-war between price-driven revenue growth and volume declines, with mixed sentiment dominating (6 of 11 filings). Portfolio-level revenue growth averaged ~2.3% YoY, but organic growth was weaker (Hershey +0.8%, Mondelez +2.1%), as volume/mix turned negative at Hershey (-10 points) and flat at Mondelez North America. Margin trends diverged sharply: Hershey's gross margin expanded ~1,350 bps to 46.1% on lower costs and tariff refunds, while Mondelez's SG&A jumped 13.3% YTD, and Altria's operating income growth was flattered by a prior-year impairment. Insider activity was sparse, but capital allocation remained shareholder-friendly: Altria expanded its buyback by $1B, Hershey repurchased $439M in stock and paid $859M in dividends, and Kimberly-Clark priced $4.9B in notes to fund its Kenvue acquisition. Management changes at Clorox (new CEO from Unilever) and Hormel (CEO role expanded) signal strategic shifts, while Church & Dwight added a director with deep consumer goods experience. The most critical developments are Hershey's raised EPS guidance (36-38.5% growth) despite volume weakness, Mondelez's tuck-in acquisition of Undercover Snacks, and Kimberly-Clark's debt-funded Kenvue deal, which will reshape the household products landscape. Overall, the sector faces persistent volume pressure and cost inflation, but strong pricing power, cost controls, and capital returns are supporting earnings.

7 high priority 4 medium 11 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 29, 2026

The 11 filings reveal a bifurcated industrials landscape: strong top-line growth and record backlogs across HVAC/building solutions (Carrier +12%, Trane +18%, Otis +6%, Republic +8%) and machinery (Caterpillar +17%), but GAAP earnings quality is deteriorating sharply due to one-time items, cost inflation, and separation expenses. Carrier's $3.1B goodwill impairment in Climate Solutions Europe and FedEx Freight's separation costs ($105M vs $30M) exemplify the gap between adjusted and GAAP results. Margin pressure is widespread: Trane's gross margin compressed ~60 bps, Caterpillar absorbed $460M of unfavorable manufacturing costs (freight/tariffs), and Republic's adjusted EPS grew only 2.1% despite 8.2% revenue growth. Insider activity is negative (Johnson Controls director sold $637K), and capital allocation remains shareholder-friendly (Republic's new $5B buyback, Carrier's $1.1B repurchases) but balance sheets are weakening (Carrier equity down 26%, cash down 30% at Trane). Forward guidance is mixed: Republic and FedEx Freight raised revenue/adjusted profit outlooks, while Carrier narrowed EPS and Trane merely reaffirmed. The common thread is a late-cycle environment where pricing and volume are decelerating (Republic yield slowed to 2.9% from 4.0%) and cost headwinds are intensifying, pressuring margins and cash flow.

5 high priority 6 medium 11 total filings
· daily

US Material Events SEC 8-K Filings — October 29, 2026

The October 29, 2026 filing batch is dominated by a mega-cap consolidation event: DoorDash's $17B acquisition of Instacart at $65/share (26% premium), a deal that will reshape U.S. grocery delivery and carries a late-2027/1H-2028 closing timeline. Operational results were sharply bifurcated: AI-infrastructure winners delivered explosive growth (Monolithic Power revenue +63.1% YoY to a record $1.20B; Bandwidth revenue +22% with Adjusted EBITDA +43%), while consumer/industrial names showed margin pressure (Floor & Decor comps -1.4%, Saia operating ratio widened 170 bps, Harley-Davidson HDMC revenue -10%). Crypto-linked earnings quality diverged from core operations: Strategy Inc reported $19.5B net income driven almost entirely by a $20.9B digital-asset gain while software revenue fell 3% and BTC Yield was -3.7% YTD. Management turnover was unusually heavy (CFO changes at Strategy, NCLH, Lionsgate; CEO change at Clorox; CRO resignation at U.S. Bancorp), and capital allocation leaned toward buybacks (MPS +$500M, Saia $250M) and M&A financing (First Mid's $70.7M Evergreen deal, Lennar's $3.795B revolver). Liquidity stress was visible at the small-cap end: Zoomcar's anti-dilution reset triggered ~331% dilution, Estrella Immunopharma deferred executive salaries, and Workhorse's TerraPod deal remains a non-binding LOI.

50 high priority 50 total filings
· daily

Insider Trading Pulse — October 29, 2026

Today's insider activity reveals a stark divergence in sentiment: while financials and small-cap healthcare saw notable insider buying, large-cap technology and consumer names experienced significant selling. The most prominent transaction was Capital One's CEO Richard Fairbank selling $9.48M in stock under a 10b5-1 plan, following option exercises, which, while pre-planned, signals potential valuation concerns. Conversely, Truist's CEO Michael Lyons purchased $1.21M in shares, demonstrating confidence in the banking sector's outlook. A wave of option exercises and sales at Sea Ltd by multiple executives, including the COO and CCO, suggests profit-taking after a strong run. Cloopen Group saw a series of disposals to the issuer by executives, likely related to tax withholding or compensation arrangements, rather than open-market sales. Overall, the day's filings show a mix of routine compensation-related transactions and strategic portfolio adjustments, with a clear tilt toward selling in high-valuation tech and buying in value-oriented financials.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 29, 2026

Today's Dow 30 filing slate is dominated by Q3 2026 earnings from four mega-cap constituents, and the unifying theme is a stark divergence between operating strength and bottom-line optics. Amazon (net sales +12% YoY to $201.9B, operating income $28.1B at a record 13.9% margin, AWS +39.3% to $46.0B) and Alphabet (revenue +24.6% YoY to $127.6B, operating income +29.9%) both posted exceptional core results, yet each saw net income fall (AMZN -2.4%, GOOGL -24.3%) purely on prior-year investment gains and other-income swings — a reminder that headline EPS is a poor proxy for these franchises this quarter. Caterpillar delivered the cleanest beat-and-raise profile (sales +17%, EPS $7.13 vs $4.88, operating margin 20.4% from 17.3%) despite $460M of combined freight and tariff headwinds, while Merck grew sales 5% and raised full-year guidance but suffered GAAP EPS -12% and severe generic erosion (JANUVIA -39%, LAGEVRIO -88%). Capital intensity is the portfolio-level story: Amazon's TTM free cash flow swung to a -$42.4B outflow on a $94.8B capex increase, and Alphabet's R&D rose 36.2% YoY — AI infrastructure spending is compressing cash conversion across hyperscalers even as margins expand. Insider activity skewed negative with three executive sales (Travelers $1.2M, Apple $824K, Goldman $92.6K), though all were modest relative to holdings and one was a pre-scheduled 10b5-1 plan. Cisco's proxy confirms a record FY2026 ($63.3B revenue, +12%; GAAP EPS +31% to $3.33) with 99% FCF return, setting up a December 15 annual meeting as the next governance catalyst.

4 high priority 6 medium 10 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 29, 2026

The five filings present a bifurcated distress landscape: three companies face imminent Nasdaq delisting (Propanc, Glucotrack, Pelican/Greenland) due to bid-price and board-independence failures, while two others (Cullen/Frost, Cloopen) execute strategic listing changes or go-private transactions. The common thread is exchange-listing risk, with Propanc and Glucotrack facing trading suspensions within days (Oct 30 and Nov 2, respectively), creating acute liquidity and capital-access threats. Cullen/Frost's voluntary NYSE-to-TXSE transfer is a notable outlier—a proactive, board-authorized move rather than a distress signal—highlighting a potential trend of Texas-based firms seeking regional exchange affiliation. Cloopen's completed merger and Form 15 filing marks the end of its public life, with dissenting shareholders now limited to Cayman Islands appraisal rights. Overall, the filings underscore a harsh environment for small-cap biotechs and micro-caps reliant on Nasdaq listing standards, with limited near-term catalysts for recovery.

5 high priority 5 total filings
· daily

Global High-Priority Regulatory Events — October 29, 2026

The October 29, 2026 filing batch is dominated by insolvency and delisting events, with 8 companies in CIRP or facing creditor petitions, and 3 delisting actions (Glucotrack, KraneShares, Cullen/Frost). M&A activity is robust but skewed toward small, tuck-in deals, with the largest being NIIT Learning's $17.6M acquisition of Bluewater Learning and Welspun's $240M US expansion. Period comparisons reveal a stark divergence: Apar Industries and Restaurant Brands Asia posted strong YoY revenue growth (21% and 24%) but margin pressure and sequential declines, while several targets (Epavo, Skyways SLS, Galenvs) show double-digit revenue contractions. Insider activity is notably absent from the enriched data, but capital allocation signals include a 5% tender offer wave from BDCs and funds, and a distressed default by Electrotherm. The most critical developments are the delisting of Glucotrack (trading suspended Oct 30) and the completion of Cadeler's redomicile tender (92% acceptance), which will reshape their shareholder bases. Overall, the batch reflects a market with ample liquidity for alternative investments but heightened credit stress in India and regulatory delisting risks in the US.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 29, 2026

October 29, 2026 delivered a bifurcated earnings day: AI/semiconductor and industrial distribution names posted blowout growth (ASE Technology revenue +45% YoY, Cohu +37%, WESCO +16.6% with backlog +80%, L3Harris book-to-bill 3.2x) while consumer, housing and protein names deteriorated sharply (Builders FirstSource gross margin -260 bps, Pilgrim's Pride EPS $0.49 vs $1.44, JELD-WEN citing going-concern risk). Margin dispersion was the defining cross-company theme: adjusted margins expanded at WTW (+150 bps), Escalade (+123 bps) and L3Harris (+200 bps), but GAAP margins compressed at Builders FirstSource (-260 bps), Pilgrim's Pride (-670 bps) and ASE's EMS segment (-90 bps), showing cost discipline separates winners from losers. Capital allocation skewed toward buybacks and dividends (Ambev $3.3B YTD repurchases vs $1.8B, Ares $1.35 dividend, California Water's 327th consecutive dividend), yet L3Harris cut buybacks 59% YoY and Proto Labs repurchases fell sharply, hinting at cash preservation. Guidance was net-positive but uneven: Proto Labs and L3Harris raised floors, WESCO lifted FY26 outlook, while Builders FirstSource only held midpoints and JELD-WEN's refinancing carries existential stakes. Distress signals clustered in small-cap resources (Chilwa 1.67-quarter runway, Resolution Minerals 0.2 quarters) and SPAC/de-SPAC dilution pipelines (Trump Media/TAE, Elroy Air, Football Manager). With Alphabet's net income down 24.3% YoY purely on an other-income swing despite 29.9% operating income growth, the market's message is clear: operating fundamentals are strong in AI-adjacent and defense/electrical infrastructure, but balance-sheet and end-market quality now dominate stock selection.

9 high priority 41 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 29, 2026

The 16 filings reveal a consumer discretionary sector grappling with margin pressures and strategic pivots. Chipotle, Ford, and eBay all reported revenue growth but earnings declines due to cost inflation and tax headwinds, while Amazon and DoorDash delivered robust top-line growth but faced profitability nuances. DoorDash's $17B acquisition of Instacart dominated the news, signaling consolidation in delivery, with a long regulatory timeline. Starbucks showed strong comparable sales but revenue fell due to China refranchising, and guidance points to a decline. GM's CAO retirement is immaterial. Overall, companies are investing heavily in growth (Amazon capex, DoorDash M&A) at the expense of near-term margins, and cost pressures are evident in labor and operating expenses. The sector faces a mixed outlook with selective opportunities in companies with strong execution and strategic clarity.

12 high priority 4 medium 16 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 29, 2026

Q3 2026 S&P 500 Healthcare earnings reveal a sector-wide tension: strong top-line growth (Lilly +39%, Gilead +13%, BMS +7%, Merck +5%, Baxter +5%, Stryker +7.7%) is being offset by aggressive acquired IPR&D spending, margin compression, and generic erosion in legacy portfolios. Lilly and Gilead both took massive IPR&D charges ($4.18B and $12.4B respectively) tied to pipeline acquisitions, pushing GAAP EPS into loss territory for Gilead and sharply lowering Lilly's full-year non-GAAP EPS guidance despite a $4.07 underlying increase. Merck, BMS, and Stryker all reported gross margin contractions (Merck -480 bps GAAP, BMS -360 bps, Stryker operating margin -280 bps), driven by product mix, amortization, and one-time charges. Insider activity at Danaher shows two senior executives (EVP and CAO) selling a combined ~$4.7M in shares, a negative signal for the healthcare conglomerate. Portfolio-level patterns include: (1) Growth portfolios outperforming legacy (BMS Growth +12% vs Legacy +1%; Gilead HIV +18% vs Veklury -69%), (2) Pricing pressure (Lilly realized prices -15%), and (3) Elevated R&D/SG&A growth (Gilead R&D +23%, SG&A +14%). Guidance updates are mixed: Lilly raised revenue but cut EPS, Merck and Baxter raised both, Stryker trimmed organic growth, and Gilead raised product sales but guided to a GAAP loss. The market implication is a continued rotation toward companies with visible pipeline catalysts and away from those facing patent cliffs and margin erosion.

5 high priority 6 medium 11 total filings